Can 5-methyltetrahydrofolate modify the phospholipid fatty acid pattern in cystic fibrosis pediatric patients?

4Citations
Citations of this article
21Readers
Mendeley users who have this article in their library.

Abstract

Recent studies have reported an imbalance between n6 and n3 fatty acids (AA and DHA) in subjects with CF. Alterations in fatty acid amounts are present in CFTR-expressing tissues, plasma and in circulating blood cells. It has been reported that the correction of polyunsaturated fatty acid deficiency reversed the organ pathologies observed in CF knockout mice. We describe a CF child with an unusual clinical course presenting high molar percentage of DHA in plasma and red cells membrane during supplementation with 5-methyltetrahydrofolate and vitamin B12. © 2006 European Cystic Fibrosis Society.

Cite

CITATION STYLE

APA

Scambi, C., Guarini, P., De Franceschi, L., & Bambara, L. M. (2006). Can 5-methyltetrahydrofolate modify the phospholipid fatty acid pattern in cystic fibrosis pediatric patients? Journal of Cystic Fibrosis, 5(3), 197–199. https://doi.org/10.1016/j.jcf.2006.01.006

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free